Integrins a6b1 and a6b4 are receptors for laminins, the main components of the basement membrane underlying the endothelial cells. In vitro, a6 integrin subunit (a6) expression at the surface of endothelial cells and their progenitors (EPCs) is up-regulated by pro-angiogenic growth factors and is crucial for adhesion, migration, and pseudotube formation. We investigated the role for a6 in post-ischaemic vascular repair in vivo.
Introduction
Neovessel formation is a crucial repair process in response to ischaemia. Ischaemic tissues secrete pro-angiogenic growth factors that promote the proliferation and migration of endothelial cells from preexisting blood vessels (angiogenesis) and the mobilization and recruitment of circulating bone marrow-derived endothelial progenitors (vasculogenesis). Extracellular matrix (ECM) proteins and their cellular receptors integrins play key roles in these multistep processes, 1, 2 acting in combination to mediate cell adhesion and to trigger signalling pathways, which in turn regulate cell proliferation, survival, motility, and cytoskeletal rearrangement. 3 Pro-angiogenic growth factors such as vascular endothelial growth factor (VEGF) or fibroblast growth factor-2 (FGF-2) increase the expression of the a6 integrin subunit (a6) at the surface of endothelial cells 4, 5 and of their progenitors (EPCs). 6, 7 This overexpression correlates with increased pseudotube formation in vitro, 5 -7 suggesting a pro-angiogenic role for a6. By binding to b1 or b4 integrin subunits, a6 forms receptors for laminins, which are major components of the ECM. Integrin a6b4 is expressed on epithelial cells and peripheral nerves and is found in adhesion junctions known as hemidesmosomes; it binds laminins 1, 2, 5, and 10. 1, 8 Integrin subunit b4 has been identified on the growing tips of sprouting blood vessels in the human neonatal foreskin 9 and on large vessels in tumours. 10 In mouse 11, 12 or human 13 epidermis, a6
deficiency is associated with the absence of hemidesmosomes, which leads to severe skin blistering and early post-natal death. No obvious vascular abnormalities have been reported in patients lacking a6 or in a6-null mice, suggesting that a6 may not play a major role in vasculogenesis during embryonic development. Integrin a6b1 is highly expressed on endothelial cells 14 and is also expressed on platelets, monocytes, macrophages, and neutrophils. It binds laminins 1, 2, 5, 8, 10, and 11. Laminins 8, 10, and 11 are present in the endothelial basement membrane and play important roles in vessel formation, maturation, and stabilization. 1 Other molecules involved in angiogenesis have been identified as ligands for a6b1, such as the angiogenic inducer CYR61, 15 netrin 4, 16 and thrombospondins 1 and 2.
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In vitro studies based on mature endothelial cells 4, 7 or on EPCs 18 showed that a6 was essential for cell adhesion, migration, and pseudotube formation. The role for a6 in cell adhesion and migration has also been demonstrated in several malignancies, 19 -21 with a6 expression contributing to the invasive properties of the tumours. The role for a6 in tumour angiogenesis has been investigated, with conflicting results. 4, 22, 23 Regarding post-ischaemic vasculogenesis, we previously used RNA interference to show that a6 was required for the recruitment of EPCs at the site of ischaemia. 18 Although
EPCs support the post-ischaemic vascular repair process, the sprouting of neovessels from the pre-existing mature vasculature also plays an important role, which could not be investigated in this previous model. To study the role for a6 in neovessel formation in vivo, via both angiogenesis and vasculogenesis, we used the cre-lox system to generate a genetic mouse model characterized by a6 gene deletion in Tie2-lineage cells (endothelial cells and subsets of haematopoietic stem cells and monocytes/macrophages). 24 We compared these mice lacking endothelial a6 (a6fl/fl-Tie2Cre+) with control mice (a6fl/fl-Tie2Cre2) in a model of unilateral hind-limb ischaemia and in a Matrigel plug assay, and we used the ex vivo aortic ring assay to specifically investigate the role for a6 in angiogenesis.
Methods

Animals
We generated a6-floxed mice as described previously 12 and bred them with mice expressing Cre recombinase under the Tie2 promoter [B6.Cg-Tg(Tek-cre)12Flv/J] and purchased from the Jackson Laboratory (Bar Harbor, ME, USA), to generate a6fl/fl-Tie2Cre+ and a6fl/ fl-Tie2Cre2 mice. All protocols were approved by the Regional Ethics Committee on Animal Experimentation (protocols P2.CBV.031.07 and CEEA34.CB.011.11.) and all experiments complied with Directive 2010/ 63/EU of the European Parliament. For all experiments, the depth of anaesthesia was confirmed by lack of tail pinch response. Before isolation of tissues (lungs, gastrocnemius muscles, Matrigel plugs, aortas, and bone marrow), mice were anaesthetized with a single intraperitoneal injection of ketamine (80 mg/kg) and xylazine (16 mg/kg) and then killed by cervical dislocation.
Genotyping by polymerase chain reaction
Polymerase chain reaction (PCR) was performed on mouse tail DNA as described in Supplementary material online.
Immunofluorescence
Frozen 10 mm-thick sections of the distal part of the gastrocnemius muscle were fixed in ice-cold acetone for 10 min and incubated with lectin-FITC (Sigma-Aldrich, St Louis, MO, USA) or with the following antibodies: rabbit anti-mouse laminin (Sigma-Aldrich), rat anti-human a6 (clone GoH3, BD Biosciences, Franklin Lakes, NJ, USA), goat anti-rabbit alexa555 (Invitrogen, Carlsbad, NM, USA), goat anti-rat alexa555 (Invitrogen), or goat anti-rat FITC (Abcam, Cambridge, MA, USA). Nuclei were stained with TOPRO3-Iodide (Thermo Fischer Scientific, Waltham, MA, USA). Sections were observed under a confocal microscope (TCS SP2, Leica, Wetzlar, Germany).
Lung endothelial cell isolation
Lungs from 7/8-week-old a6fl/fl-Tie2Cre+ and a6fl/fl-Tie2Cre2 mice were dissociated into a single-cell suspension using a mouse lung dissociation kit (Miltenyi Biotec, Bergisch Gladbach, Germany) with the gentle MACS TM dissociator, according to the manufacturer's protocol. Endothelial cells were then isolated by magnetic cell sorting using CD146 Microbeads (Miltenyi Biotec) and analysed by flow cytometry.
Isolation and culture of late-outgrowth endothelial progenitors from peripheral blood
Peripheral blood from a6fl/fl-Tie2Cre+ and a6fl/fl-Tie2Cre2 mice was collected by cardiac puncture, after general anaesthesia with a single intraperitoneal injection of ketamine (80 mg/kg) and xylazine (16 mg/kg). The mice were then killed by cervical dislocation. Blood was diluted in an equal volume of RPMI 2% foetal calf serum (FCS). Mononuclear cells were isolated by density-gradient centrifugation with Ficoll (Sigma-Aldrich), washed and plated on 0.2% gelatine-coated 24-well plastic culture dishes in EGM-2 (Lonza, Walkersville, MD, USA), and placed in an incubator at 378C with 5% CO 2 . After 4 days, non-adherent cells were removed as the medium was changed. After 10 -20 days of culture, cobblestoneshaped colonies became microscopically visible. The phenotype of these late-outgrowth EPCs (CD34+ CD452 CD31+) was verified by flow cytometry.
Flow cytometry analysis of lung endothelial cells and late-outgrowth endothelial progenitors
Cells were washed in HBSS 2% FCS and incubated with the antibodies CD31-FITC, CD34-PE, and CD104-PE (b4) (Abd Serotec, Düsseldorf, Germany); CD45-PE-Cy5, VEGFR2-PE, CD29-FITC (b1), CD49b-APC (a2), CD49e-PE (a5), and CD49f-PE (a6) (BD Biosciences); or CD49c-PE (a3) (R&D Systems, Minneapolis, MN, USA); or with an isotype-matched irrelevant antibody from the same manufacturer. Cells were analysed on a FACS Calibur flow cytometer, using Cell Quest Pro software (BD Biosciences).
Unilateral hind-limb ischaemia 2.7.1 Surgical procedure
Male mice aged 7 -8 weeks (20 -25 g) were anaesthetized with a single intraperitoneal injection of ketamine (80 mg/kg) and xylazine (16 mg/kg). The femoral artery and vein were separated from the femoral nerve, ligated, and excised from proximal to the superficial epigastric artery to proximal to the bifurcation of the saphena and popliteal arteries.
Laser Doppler perfusion imaging
On days 3, 7, and 14 after ischaemia induction, mice were anaesthetized with a single intraperitoneal injection of pentobarbital (50 mg/kg) and placed on a heating pad at 378C. Laser Doppler perfusion imaging (LDPI) was used to assess leg tissue perfusion as described previously. 18 The results were expressed as the ratio of perfusion in the ischaemic (left) leg to perfusion in the non-ischaemic (right) leg. On day 14 after ischaemia induction, ischaemic and non-ischaemic gastrocnemius muscles were collected and frozen slowly in isopentane solution cooled in liquid nitrogen, before being stored at -808C until histological analysis.
Capillary density determination
Frozen 10 mm-thick sections of the distal part of the gastrocnemius muscle were fixed in ice-cold acetone for 10 min, incubated for 1 h with a rat anti-mouse CD31 monoclonal antibody (clone MEC 13.3, BD Biosciences), and then incubated with a goat anti-rat secondary antibody coupled to FITC (Abcam). Sections were examined by a blinded observer using a confocal microscope (TCS SP2, Leica). Ten fields were examined per section and vessels were counted using Histolab TM software (Microvision Instruments, Evry, France).
Quantification of Tie2-expressing macrophages
Frozen 10 mm-thick sections of ischaemic gastrocnemius muscles were fixed in ice-cold acetone for 10 min and then sequentially incubated with the following antibodies: rat anti-mouse F4/80 (Abd Serotec), goat anti-rat FITC, biotinylated rat anti-mouse Tie2 (eBiosciences, San Diego, CA, USA), and streptavidin-alexa555 (Invitrogen). Sections were examined by a blinded observer using a confocal microscope (TCS SP2, Leica). Ten fields were examined per section and the numbers of Role for a6 in post-ischaemic angiogenesis Tie2-expressing macrophages (TEMs) (F4/80+ Tie2+) and total macrophages (F4/80+) were determined using Image J and Histolab TM (Microvision) software. Results were expressed as the percentage of TEMs in the total macrophage population.
Quantification of EPC mobilization
Mice were anaesthetized with a single intraperitoneal injection of ketamine (80 mg/kg) and xylazine (16 mg/kg), and 100 mL of blood was collected at the retro-orbital sinus just before ischaemia (baseline) and 30 min after ischaemia. Blood was incubated with a rat anti-mouse CD34-PE antibody (Abd Serotec), a rat anti-mouse CD45-PECy5 antibody (BD Biosciences), and a rat anti-mouse CD31-FITC antibody (Abd Serotec) or with isotype control antibodies from the same manufacturers. Red blood cells were lysed using FACS lysing solution. Cells were then washed in phosphate-buffered saline (PBS) and transferred to Trucount w tubes (BD Biosciences) to obtain absolute cell counts. At least 50 000 cells were analysed on a flow cytometer, using Cell Quest Pro software (BD Biosciences). EPCs were defined as cells positive for the progenitor marker CD34, negative for the leucocyte common antigen CD45, and positive for the endothelial marker CD31. 25 Results were expressed as the ratio of the number of CD34+ CD452 CD31+ cells per millilitre of blood 30 min after ischaemia over the number of CD34+ CD452 CD31+ cells per millilitre of blood at the baseline.
Matrigel plug assay
Ice-cold growth factor-reduced Matrigel (BD Biosciences) was adjusted at a protein concentration of 8 mg/mL and mixed with PBS or FGF-2 (R&D Systems) to obtain a final concentration of 300 ng/mL and then kept on ice. Mice aged 8 weeks (20 -25 g) were anaesthetized with a single intraperitoneal injection of ketamine (80 mg/kg) and xylazine (16 mg/kg), and 500 mL of Matrigel was injected subcutaneously at the left dorsal posterior flank. Two weeks later, plugs were harvested and homogenized in RIPA lysis buffer, using an Ultra-Turrax homogenizer. After the removal of debris by centrifugation, the haemoglobin concentration was measured using Drabkin's reagent (Sigma-Aldrich) and the soluble VEGFR2 (sVEGFR2) concentration was measured using an ELISA kit (Quantikine, R&D Systems). Alternatively, plugs were fixed overnight in 4% paraformaldehyde, embedded in paraffin, sectioned, and stained with Masson's trichrome. Slides were imaged using a Leica microscope to count the functional blood vessels (with red blood cells circulating in the lumen).
Ex vivo aortic ring assay
Thoracic aortas from 6-week-old a6fl/fl-Tie2Cre+ and a6fl/fl-Tie2Cre2 mice were dissected, the fat layer and adventitia were removed, and 1 mm-long rings were prepared, as described previously. 26 Individual rings were embedded in growth factor-reduced Matrigel or rat tail collagen I (BD Biosciences), in a 48-well plate. Endothelial basal culture medium (EBM2 + 2% FCS; Lonza) or endothelial growth culture medium (EGM-2; Lonza) was then added to the wells. The rings were cultured in a humidified atmosphere at 378C, with 5% CO 2 . Neovessel outgrowth was observed and imaged using a phased microscope over a period of 5 -12 days. The surface area covered by capillary-like structures sprouting from aortic rings on day 7 was measured using Histolab TM software (Microvision).
Statistical analysis
Results are expressed as means + SEM. Data were analysed using ANOVA followed by Fisher's PLSD post hoc test, implemented with StatView software (SAS, Cary, NC, USA). Differences were assumed to be significant when P , 0.05.
Results
Specific deletion of a6 in Tie2-lineage cells
a6-null mice die at birth from severe skin blistering due to the absence of hemidesmosomes. 11 To study the role for a6 in angiogenesis, we generated a mouse line characterized by specific a6 gene deletion in Tie2Cre-positive cells. Tie2Cre transgenic mice express Cre recombinase under the control of the Tie2 promoter, which has been shown to provide uniform expression in endothelial cells during embryogenesis and adulthood 24 and which is commonly used to generate conditional knockout mice for angiogenesis research. We crossed a6fl/fl with Tie2Cre mice to generate a6fl/ fl-Tie2Cre+ and a6fl/fl-Tie2Cre2 mice. These mice were viable and born in normal Mendelian proportions.
Polymerase chain reaction
The PCR of samples from a6fl/fl-Tie2Cre+ mice generated bands at 700 bp for the Cre insert, 154 bp for the a6-floxed allele, and 120 bp for the wild-type allele ( Figure 1A ).
Immunofluorescence
Immunofluorescence experiments showed that a6 was expressed on blood vessels and was associated with laminins in a6fl/fl-Tie2Cre2 mice ( Figure 1B ; see Supplementary material online, Figure S1 ). In a6fl/ fl-Tie2Cre+ mice, endothelial a6 deletion was complete in ischaemic tissues ( Figure 1B ) and non-ischaemic tissues (see Supplementary material online, Figure S1 ).
Flow cytometry
The expression of a6 at the surface of mature lung endothelial cells and of late-outgrowth endothelial progenitors from a6fl/fl-Tie2Cre+ mice was inhibited compared with a6fl/fl-Tie2Cre2 mice ( Figure 1C and D). Late-outgrowth endothelial progenitors were positive for CD31, CD34, and VEGFR2 and negative for CD45 ( Figure 1D ). The expression of b1, b4, a2, a3, and a5 integrin subunits and of CD31 and VEGFR2 at the surface of lung endothelial cells from a6fl/fl-Tie2Cre+ mice was unchanged compared with a6fl/ fl-Tie2Cre2 mice ( Figure 1C ).
Endothelial deletion of a6 decreases post-ischaemic vascular repair after hind-limb ischaemia 3.2.1 Laser Doppler perfusion imaging
In control mice (a6fl/fl-Tie2Cre2), blood flow in the ischaemic limb increased progressively from days 3 to 14, reaching 57% of the blood flow in the non-ischaemic limb (with no further improvement on day 21, data not shown). There was no genotype-dependent difference in blood perfusion of the non-ischaemic limb. In contrast, reperfusion of the ischaemic limb was significantly reduced in a6fl/fl-Tie2Cre+ mice (n ¼ 8) compared with a6fl/fl-Tie2Cre2 mice (n ¼ 10; Figure 2A and B). Endothelial a6 deletion decreased the ischaemic to non-ischaemic limb blood-flow ratio by 41% on day 7 (P , 0.05 vs. a6fl/fl-Tie2Cre2 mice) and by 34% on day 14 (P , 0.01 vs. a6fl/fl-Tie2Cre2 mice; Figure 2A ). Representative photomicrographs and quantitative analysis of capillary density of cryosections from ischaemic and non-ischaemic gastrocnemius muscles from a6fl/fl-Tie2Cre2 (filled square, n ¼ 6) and a6fl/fl-Tie2Cre+ (open square, n ¼ 6) mice 14 days after ischaemia onset; capillaries are stained in green with an anti-CD31 antibody. (B) Representative photomicrographs and quantification of TEMs and total macrophages in cryosections from ischaemic gastrocnemius muscles from a6fl/fl-Tie2Cre2 (filled square, n ¼ 6) and a6fl/fl-Tie2Cre+ (open square, n ¼ 6) mice 14 days after ischaemia onset; cells are stained in green with an anti-F4/80 antibody and in red with an anti-Tie2 antibody. Data are mean + SEM. *P , 0.05, ***P , 0.001.
Role for a6 in post-ischaemic angiogenesis
Capillary density
There was no genotype-dependent difference in the capillary density of non-ischaemic gastrocnemius muscles. In control mice (a6fl/ fl-Tie2Cre2), capillary density was increased in ischaemic muscles, compared with non-ischaemic muscles (P , 0.001). Capillary density was not significantly different between ischaemic and non-ischaemic muscles from a6fl/fl-Tie2Cre+ mice. Neovessel formation was inhibited in ischaemic muscles from a6fl/fl-Tie2Cre+ mice (n ¼ 6), compared with a6fl/fl-Tie2Cre2 mice (n ¼ 6; P , 0.001), with a 40% decrease in the ischaemic/non ischaemic leg ratio (P ¼ 0.013; Figure 3A ).
Infiltration of Tie2-expressing macrophages
The proportion of TEMs (F4/80+ Tie2+) in the total population of macrophages (F4/80+) was reduced by 40% in ischaemic muscles from a6fl/fl-Tie2Cre+ mice (n ¼ 6), compared with a6fl/fl-Tie2Cre2 mice (n ¼ 6; P , 0.001; Figure 3B ).
Endothelial deletion of a6 decreases post-ischaemic endothelial progenitor mobilization
Ischaemia induces mobilization of EPCs from the bone marrow to the circulation, 27 and the circulating EPCs contribute to post-ischaemic vascular repair. Here, mobilization of EPCs (defined as CD34+ CD452 CD31+ cells) 30 min after ischaemia was decreased in a6fl/fl-Tie2Cre+ mice (n ¼ 8), compared with a6fl/fl-Tie2Cre -mice (n ¼ 7; P , 0.05; Figure 4) . At the baseline, there was no significant genotype-dependent difference in EPC counts in blood (data not shown) or bone marrow (see Supplementary material online, Figure S2 ).
Endothelial deletion of a6 decreases FGF-2-induced Matrigel plug vascularization
There was no significant genotype-dependent difference in the vascularization of plugs containing PBS, which were poorly vascularized in a6fl/fl-Tie2Cre2 and a6fl/fl-Tie2Cre+ groups (n ¼ 5 per group). In control mice (a6fl/fl-Tie2Cre2), FGF-2 (300 ng/mL) induced a five-fold increase in plug vascularization (P , 0.001; Figure 5A -C ), with a four-fold increase in the haemoglobin concentration (P , 0.01; Figure 5D ) and a 3.7-fold increase in the sVEGFR2 concentration (P , 0.001; Figure 5E ), compared with PBS. In contrast, when endothelial a6 was deleted, FGF-2-induced angiogenesis was markedly diminished, with no significant difference vs. PBS. Plugs supplemented with FGF-2 from a6fl/fl-Tie2Cre+ mice were less vascularized (P , 0.001) than those from a6fl/fl-Tie2Cre2 mice (n ¼ 10 per group; Figure 5A -C ), with the haemoglobin concentration being 63% lower (P , 0.01; Figure 5D ) and the sVEGFR2 concentration 45% lower (P , 0.001; Figure 5E ).
Endothelial deletion of a6 decreases ex vivo neovessel formation from mature blood vessels
There was no significant genotype-dependent difference in microvessel outgrowth from aortic rings cultured in endothelial basal medium, which produced only a few sprouts, in both collagen and Matrigel matrix (n ¼ 11 per group; Figure 6A and B). Culturing of aortic rings in endothelial growth medium led to the sprouting of capillary-like structures, followed by extension and increasing complexity of the network, with branching out at several levels; complexity was greatest on day 7. However, rings from a6fl/fl-Tie2Cre+ mice cultured in endothelial growth medium and embedded in Matrigel displayed reduced sprouting of tubular structures, compared with a6fl/ fl-Tie2Cre2 mice, with a surface area covered by sprouts reduced by half (P , 0.001; Figure 6A ). In contrast, there was no significant genotype-dependent difference when rings were embedded in collagen ( Figure 6B) . We verified the expression of a6 in rings from a6fl/fl-Tie2Cre2 mice embedded in Matrigel (see Supplementary material online, Figure S3 ).
Discussion
In vitro, a6 is involved in cell adhesion, migration, and tube formation by endothelial cells 4, 7 and their progenitors. 18 In a previous study involving the injection of human EPCs transfected with siRNA against a6 into a nude mouse model of hind-limb ischaemia, we demonstrated that a6 was required for EPC recruitment at the site of ischaemia and for the promotion of vascular repair (vasculogenesis). Here, to study the role for a6 in post-ischaemic vascular repair in vivo, we generated the genetic mouse model a6fl/ fl-Tie2Cre+ characterized by a6 gene deletion in Tie2-expressing cells. Tie2 is expressed not only by endothelial cells and EPCs, but also by subsets of haematopoietic stem cells, monocytes, and macrophages. The a6fl/fl-Tie2Cre+ mice were viable and exhibited no obvious vascular aberrations in unchallenged tissues. In contrast, in ischaemic tissues, the absence of endothelial a6 impaired ischaemic muscle revascularization and, consequently, limb reperfusion. Our results indicate that a6 plays a major role in post-ischaemic vascular repair but is dispensable for blood vessel development during the embryonic stage. Hiran et al. 9 also found that a6b4 was not required for developmental angiogenesis in mice. Basement membrane composition and integrin expression patterns on endothelial cells vary across development stages, vessel types, and endothelium activation states. Laminin 8 is expressed by all endothelial cells, at all stages of development, and is up-regulated by inflammatory cytokines and growth factors, whereas laminin 10 is found only in the basement membrane of post-natal mature endothelium 28 and is up-regulated only by strong pro-inflammatory signals, 29 such as ischaemia. Integrin a6b1 has a higher affinity for laminin 10 than for laminin 8, 1 which may explain these functional differences. Post-ischaemic revascularization involves at least three different mechanisms: the formation of new blood vessels from pre-existing blood vessels (angiogenesis); mobilization and recruitment of EPCs (vasculogenesis); and recruitment of macrophages secreting pro-angiogenic growth factors. For each of these three mechanisms, we investigated whether a6 was involved.
Using the aortic ring assay to specifically investigate the role for a6 in angiogenesis, we found that endothelial a6 deletion decreased neovessel outgrowth from aortic rings embedded in Matrigel. These results are in accordance with in vitro studies, showing that a6 is required for endothelial cell migration and tube formation, 4 -7,18 and confirm the role for a6 in neovessel formation.
During ischaemia, EPCs are mobilized from the bone marrow to the circulation and are attracted by VEGF or stromal-derived factor-1 to the site of ischaemia, where they support vascular repair. 27 Using transplantation experiments, Qian et al. 30 showed that a6 was involved in the homing of haematopoietic stem cells to the bone marrow. As haematopoietic stem cells and EPCs may arise from a common precursor, we investigated whether a6 was also involved in EPC homing or mobilization mechanisms. We demonstrated previously that a6 was involved in EPC adhesion and AKT phosphorylation after adhesion on laminin and that a6 was required for EPC recruitment at the site of ischaemia. 18 Here, using flow cytometry, we found that EPC mobilization was diminished in mice lacking endothelial a6, whereas EPC counts in bone marrow were unchanged. The bone marrow is highly vascularized, and cells that home to the bone marrow or egress out of it must actively cross endothelial and ECM barriers, a step that involves adhesion molecules. 31 This transendothelial migration step may be impaired in a6fl/fl-Tie2cre+ mice, as a6 is required for EPC migration through laminin. 18 In this study and in our previous study, we investigated 'late' EPCs, also known as endothelial colony-forming cells. These cells are positive for CD34 and CD31 and negative for the myeloid marker CD45. Femoral artery ligation induces severe ischaemia and inflammation, with massive infiltration by monocytes/macrophages. Tie2 is expressed by a subset of macrophages called TEMs, which secrete Role for a6 in post-ischaemic angiogenesis pro-angiogenic growth factors such as VEGF and promote neovessel formation in tumours and endometriotic lesions. 32 TEM adhesion and migration in ischaemic tissues may be mediated by a6, which consequently may promote post-ischaemic vascular repair. We therefore counted TEMs in ischaemic muscles. The results showed that Tie2-dependent a6 deletion decreased TEM recruitment at the site of ischaemia.
To study the role for a6 in neovessel formation in a more strictly controlled environment characterized by less inflammation than ischaemia, we injected subcutaneously a basement membrane extract (Matrigel) rich in laminin ( 60%), collagen IV, and entactin, with and without FGF-2 supplementation. Endothelial a6 deletion inhibited FGF-2-induced Matrigel plug vascularization. Other authors 22 showed that a6b1 was involved in FGF-2-induced angiogenesis in chicken chorioallantoic membrane. Germain et al. 23 also generated an endothelial-specific genetic mouse model, which was under Tie1 promoter control. They showed that endothelial a6 deletion increased the vascularization of VEGF-treated sponges implanted subcutaneously. This apparent discrepancy is ascribable to the involvement of a6b1 in endothelial cell adhesion and migration on laminin, which is present in Matrigel but not in sponges. Interestingly, in the aortic ring assay, we found that a6 was required for the sprouting of capillary-like structures from aortic rings embedded in laminin-containing matrix (Matrigel) but not in collagen. Here also, our conclusions are in accordance with those of Primo et al. 22 but differ from those of Germain et al., 23 who did not use a laminin-containing matrix. Laminins play a crucial role in angiogenesis. For example, laminin 8-deficient mice exhibit defects in vessel integrity and stability and aberrant branching. 33 A recent study demonstrated that binding of a6b1 and a2b1 to laminin triggers Dll4 expression and Notch signalling, this last being involved in tip vs. stalk cell selection. 34 This study supports our findings, suggesting a crucial role for a6 in functional vessel patterning. The ECM specificity of the response can explain why studies into the role for a6 in tumour angiogenesis found opposite results. Blocking antibodies directed against a6 inhibited tumour angiogenesis in a breast carcinoma xenograft model and in rip-tag2 mice developing pancreatic tumors, 4,22 whereas Germain et al. 23 found that endothelial a6 deletion in mice enhanced tumour angiogenesis in melanoma and lung carcinoma syngeneic tumour models. However, ECM composition may differ between these models. Moreover, in the a6fl/ fl-Tie1Cre+ mice generated by Germain et al., 23 bone marrowderived angiogenesis was not affected, and a6 deletion in endothelial cells increased VEGFR2 expression. In our a6fl/fl-Tie2cre+ model, mature endothelial cells, as well as bone marrow-derived EPCs and TEMs, were affected by a6 deletion. In addition, the loss of a6 was Figure 6 Tie2-dependent a6 deletion decreases ex vivo neovessel sprouting from mature blood vessels in Matrigel but not in collagen. Representative photomicrographs and quantitative analysis of the surface area covered by capillary-like structures sprouting from aortic rings isolated from a6fl/ fl-Tie2Cre2 (filled square) and a6fl/fl-Tie2Cre+ (open square) mice, embedded in Matrigel (A) or in collagen (B), and cultured for 7 days in endothelial basal medium (EBM2 + 2% FCS) or endothelial growth medium (EGM-2; n ¼ 11 per group). Data are mean + SEM. *P , 0.05, **P , 0.01 and ***P , 0.001.
not compensated by the overexpression of VEGFR2 or other integrin subunits. Although post-ischaemic vascular repair and tumour angiogenesis are different processes in terms of kinetics and microenvironment, these differences between the Tie1Cre and Tie2Cre models may also explain the discrepancy between our results and those reported by Germain et al.
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In summary, we demonstrate that a6 plays a major role in postischaemic revascularization and reperfusion, as it is required by endothelial cells (attracted by growth factors) to invade the ECM and form functional blood vessels. Aortic ring assay results indicate that a6 mediates neovessel sprouting from pre-existing mature blood vessels. In addition, a6 is involved in EPC mobilization from bone marrow after ischaemia and in recruiting pro-angiogenic TEMs at the site of ischaemia.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
